Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.60 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.60 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.50 |
| ▸ | FNTA | P49354 | 1/20 | 0.44 |
| ▸ | FNTB | P49356 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.35 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thioglycolic Acid SCHEMBL7078844 | 1.00 | GPR84 (0.60) | GPR84FFAR1FFAR4CAMK2AFNTA | |
| 1,6-Hexanediol SCHEMBL11399082 | 1.00 | GPR84 (0.60) | GPR84FFAR1FFAR4CAMK2AFNTA | |
| 1,5-Pentanediol SCHEMBL11585670 | 1.00 | GPR84 (0.60) | GPR84FFAR1FFAR4CAMK2AFNTA | |
| Thioglycolic Acid SCHEMBL97046 | 1.00 | GPR84 (0.60) | GPR84FFAR1FFAR4CAMK2AFNTA | |
| Thioglycolic Acid SCHEMBL96894 | 1.00 | GPR84 (0.60) | GPR84FFAR1FFAR4CAMK2AFNTA | |
| Thioglycolic Acid SCHEMBL11235420 | 1.00 | GPR84 (0.60) | GPR84FFAR1FFAR4CAMK2AFNTA | |
| 1,4-Butanediol SCHEMBL451336 | 0.97 | GPR84 (0.55) | GPR84FFAR1FFAR4CAMK2AFNTA | |
| 1,4-Butanediol SCHEMBL60932 | 0.97 | GPR84 (0.55) | GPR84FFAR1FFAR4CAMK2AFNTA | |
| 1,4-Butanediol SCHEMBL31453278 | 0.97 | GPR84 (0.55) | GPR84FFAR1FFAR4CAMK2AFNTA | |
| Thioglycolic Acid SCHEMBL98408 | 0.90 | CAMK2A (0.53) | GPR84FFAR1FFAR4CAMK2AFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113956477-B | Curing composition and application thereof, and cured polymer material and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-10-13 | — | — | CN | claimed |
| US-4093780-A | ESTERS AND POLYESTERS OF THIOGLYCOLIC ACID | NORANDA MINES LIMITED (CA) | 1978-06-06 | — | — | US | claimed |
| US-12492293-B2 | Multi-component systems for preparing foamed products | ARKEMA FRANCE (FR) | 2025-12-09 | — | — | US | disclosed |
| EP-3643735-B1 | PHOTOCHROMIC POLYROTAXANE COMPOUND, AND CURABLE COMPOSITION CONTAINING SAID PHOTOCHROMIC POLYROTAXANE COMPOUND | TOKUYAMA CORP (JP) | 2024-07-31 | — | — | EP | disclosed |
| US-11912813-B2 | Urethane resin using polyrotaxane, and pad for polishing | TOKUYAMA CORPORATION (JP) | 2024-02-27 | — | — | US | disclosed |
| US-11767467-B2 | Photochromic compound and curable composition containing said photochromic compound | TOKUYAMA CORPORATION (JP) | 2023-09-26 | — | — | US | disclosed |
| EP-3891210-B1 | MULTI-COMPONENT SYSTEMS FOR PREPARING FOAMED PRODUCTS | ARKEMA FRANCE (FR) | 2023-08-23 | — | — | EP | disclosed |
| EP-3345954-B1 | POLYROTAXANE, PRODUCTION METHOD THEREFOR, AND OPTICAL COMPOSITION CONTAINING SAID POLYROTAXANE | TOKUYAMA CORP (JP) | 2023-07-05 | — | — | EP | disclosed |
| EP-3653615-B1 | CHROMENE COMPOUND, CURABLE COMPOSITION COMPRISING SAME, AND OPTICAL ARTICLE COMPRISING CURED PRODUCT FORMED OF CURABLE COMPOSITION | TOKUYAMA CORP (JP) | 2023-03-01 | — | — | EP | disclosed |
| US-11578174-B2 | Polyrotaxane, production method therefor, and optical composition containing said polyrotaxane | TOKUYAMA CORPORATION (JP) | 2023-02-14 | — | — | US | disclosed |
| US-11401276-B2 | Chromene compound, curable composition comprising the compound, and optical article including a cured body of the curable composition | TOKUYAMA CORPORATION (JP) | 2022-08-02 | — | — | US | disclosed |
| US-20120157564-A1 | ENERGY RAY-CURABLE ELASTOMER COMPOSITION | BRIDGESTONE CORPORATION (JP) | 2012-06-21 | — | — | US | disclosed |
| EP-2426162-A1 | ENERGY-RAY-CURABLE ELASTOMER COMPOSITION, MATERIAL FOR GASKET, GASKET, AND HARD DISK DEVICE | Bridgestone Corporation (JP) | 2012-03-07 | — | — | EP | disclosed |
| US-20120041096-A1 | ENERGY-RAY-CURABLE ELASTOMER COMPOSITION, MATERIAL FOR GASKET, GASKET, AND HARD DISK DEVICE | BRIDGESTONE CORPORATION (JP) | 2012-02-16 | — | — | US | disclosed |
| US-20110014483-A1 | PRIMER COMPOSITION | MITSUI CHEMICALS, INC. | 2011-01-20 | — | — | US | disclosed |
| EP-2258780-A1 | PRIMER COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2010-12-08 | — | — | EP | disclosed |
| EP-0609061-B1 | Polymerizable composition, polymer, organic glass and ophthalmic lens | TOKUYAMA CORP (JP) | 1999-09-29 | — | — | EP | disclosed |
| US-5475074-A | Copolamerizable monomers containing vinyl benzyl compound, 2,4-diphenyl-4-methyl-1-pentene and an acrylic momomer; also contains mercapto, hindered phenol and azo compounds; high refractive index, heat and radiation resistance | TOKUYAMA CORPORATION (JP) | 1995-12-12 | — | — | US | disclosed |
| EP-0609061-A2 | Polymerizable composition, polymer, organic glass and ophthalmic lens | TOKUYAMA CORPORATION (JP) | 1994-08-03 | — | — | EP | disclosed |
| US-4093780-A | ESTERS AND POLYESTERS OF THIOGLYCOLIC ACID | NORANDA MINES LIMITED (CA) | 1978-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11401276-B2 | Chromene compound, curable composition comprising the compound, and optical article including a cured body of the curable composition | INCENP, SMCHD1, ILK | GPR84 2646/4885FFAR1 1319/4885FFAR4 1634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.